Stay updated with breaking news from Nasdaq Gmab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vestmark Advisory Solutions Inc. raised its stake in Genmab A/S (NASDAQ:GMAB – Free Report) by 28.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 35,656 shares of the company’s stock after buying an additional 7,905 shares during the period. Vestmark […]
Genmab A/S (NASDAQ:GMAB – Get Free Report) is scheduled to release its earnings data before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of $0.16 per share for the quarter. Genmab A/S has set its FY 2024 guidance at EPS.Investors that wish to register for the company’s conference call […]
Genmab A/S (NASDAQ:GMAB – Get Free Report) has been given a consensus rating of “Hold” by the thirteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and eight have issued a buy recommendation on […]
Genmab A/S (NASDAQ:GMAB – Free Report) – Investment analysts at William Blair dropped their FY2025 earnings per share (EPS) estimates for shares of Genmab A/S in a research report issued to clients and investors on Wednesday, April 3rd. William Blair analyst M. Phipps now expects that the company will post earnings per share of $1.07 […]
HC Wainwright reiterated their buy rating on shares of Genmab A/S (NASDAQ:GMAB – Free Report) in a research report sent to investors on Thursday, Benzinga reports. The brokerage currently has a $50.00 target price on the stock. Other equities analysts have also issued research reports about the company. Morgan Stanley reaffirmed an underweight rating on […]